Cyrus J. Lawrence’s DexCom DXCM Stock Holding History

Cyrus J. Lawrence’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$11K	–	167
2024 Q2	$11K	Buy	+100	New	+$12.6K	﹤0.01%	167

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Cyrus J. Lawrence's DXCM Position: Q3 2024 in Review

Cyrus J. Lawrence sold out of DexCom (DXCM) in Q3 2024, closing a stake of 100 shares — an estimated $11K sold.

Cyrus J. Lawrence first reported a position in DXCM in Q2 2024 and held it in 1 quarter. The position peaked at $11K in Q2 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Cyrus J. Lawrence reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
Cyrus J. Lawrence sold 100 DexCom shares in Q3 2024, an estimated $11K.
Cyrus J. Lawrence first reported a position in DexCom in Q2 2024 and held it in 1 quarter.
Cyrus J. Lawrence's DexCom position peaked at $11K in Q2 2024.
889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Cyrus J. Lawrence's 13F filing for Q3 2024, filed 12 Nov 2024.